FLSM
ZYME icon

Frazier Life Sciences Management’s Zymeworks ZYME Stock Holding History

Frazier Life Sciences Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-610,000
Closed -$5.51M – 51
2023
Q1 		$5.51M Hold
610,000
– – 0.4% 40
2022
Q4 		$4.79M Buy
+610,000
New +$4.29M 0.3% 39

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Frazier Life Sciences Management's ZYME Position: Q2 2023 in Review

Frazier Life Sciences Management sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 610,000 shares — an estimated $5.51M sold.

Frazier Life Sciences Management first reported a position in ZYME in Q4 2022 and held it in 2 quarters. The position peaked at $5.51M in Q1 2023. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

  • Frazier Life Sciences Management reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
  • Frazier Life Sciences Management sold 610,000 Zymeworks shares in Q2 2023, an estimated $5.51M.
  • Frazier Life Sciences Management first reported a position in Zymeworks in Q4 2022 and held it in 2 quarters.
  • Frazier Life Sciences Management's Zymeworks position peaked at $5.51M in Q1 2023.
  • 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Frazier Life Sciences Management's 13F filing for Q2 2023, filed 14 Aug 2023.